Literature DB >> 7173858

Homozygous Robertsonian translocations in a fetus with 44 chromosomes.

C Rockman-Greenberg, M Ray, J A Evans, N Canning, J L Hamerton.   

Abstract

We report the unique finding of a human fetus with 44 chromosomes with homozygous 14;21 translocations. This fetus appeared phenotypically normal but the long-term neurodevelopmental outcome had this pregnancy continued could not be predicted. We speculate one 14;21 translocation was inherited from her father and one arose de novo being maternal in origin. A previous sibling with psychomotor retardation has an abnormal chromosome complement of 45,XX,dup(7)(q21 leads to pter), t(14;21)(p11;q11). The mother's underlying disease, systemic lupus erythematosis (SLE), and her prior chemotherapy may have contributed to the appearance of these chromosome aberrations. It is interesting that although 14;21 translocations are among the commonest structural chromosome rearrangements in man, there are no previous reports in newborn surveys of a child with 44 chromosomes resulting from the mating of two identical Robertsonian translocation carrier parents.

Entities:  

Mesh:

Year:  1982        PMID: 7173858     DOI: 10.1007/bf00296437

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  A simplified technique for in vivo analysis of sister-chromatid exchanges using 5-bromodeoxyuridine tablets.

Authors:  J W Allen; C F Shuler; R W Mendes; S A Latt
Journal:  Cytogenet Cell Genet       Date:  1977

2.  Neonatal lupus erythematosus.

Authors:  H H Bremers; L E Golitz; W L Weston; W G Hays
Journal:  Cutis       Date:  1979-09

3.  Systemic lupus erythematosus in pregnancy.

Authors:  L D Devoe; R L Taylor
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

4.  Systemic lupus erythematosus and pregnancy.

Authors:  E C Tozman; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1980 Sep-Oct       Impact factor: 4.666

5.  Cytogenetic analysis on children born of parents treated with immunosuppressive drugs.

Authors:  M G McGeown; N C Nevin
Journal:  Proc Eur Dial Transplant Assoc       Date:  1978

6.  Pregnancy and systemic lupus erythematosus.

Authors:  M T Houser; A J Fish; G E Tagatz; P P Williams; A F Michael
Journal:  Am J Obstet Gynecol       Date:  1980-10-15       Impact factor: 8.661

  6 in total
  7 in total

1.  Partial trisomy and partial monosomy resulting from a reciprocal segregating in a large family.

Authors:  Gopalrao V N Velagaleti; Judy C Hawkins; Neli I Panova; Lillian H Lockhart
Journal:  Indian J Pediatr       Date:  2008-09       Impact factor: 1.967

Review 2.  Homozygous paracentric inversion 12 in a mentally retarded boy: a case report and review of the literature.

Authors:  H A Price; S H Roberts; K M Laurence
Journal:  Hum Genet       Date:  1987-02       Impact factor: 4.132

3.  Intrachromosomal triplication of distal 7p.

Authors:  H Rivera; L Bobadilla; A Rolon; J Kunz; J A Crolla
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

4.  Human chromosome variation with two Robertsonian translocations.

Authors:  R Morgan; H Bixenman; F Hecht
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Homozygosity for a Robertsonian Translocation (13q;14q) in a Phenotypically Normal 44, XX Female with a History of Recurrent Abortion and a Normal Pregnancy Outcome.

Authors:  Mohammad Miryounesi; Mehdi Diantpour; Elahe Motevaseli; Soudeh Ghafouri-Fard
Journal:  J Reprod Infertil       Date:  2016 Jul-Sep

6.  One pedigree we all may have come from - did Adam and Eve have the chromosome 2 fusion?

Authors:  Paweł Stankiewicz
Journal:  Mol Cytogenet       Date:  2016-09-26       Impact factor: 2.009

7.  The Survey of Double Robertsonian Translocation 13q; 14q in the Pedigree of 44; XX Woman: A Case Report.

Authors:  Nasrin Malekpour; Seyed Mohammad Amin Kormi; Mahtab Azadbakht; Meysam Yousefi; Mohammad Hasanzadeh-Nazar Abadi
Journal:  Int J Mol Cell Med       Date:  2017-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.